GlassScriptPhysician profile
Sung Joon Han
NPI 1639112659
$8,722.02
in general payments reported to CMS, 2019-2025
47 companies · $1,613 in 2025
The $1,613 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,670 · 2020: $834 · 2021: $1,216 · 2022: $934 · 2023: $1,157 · 2024: $1,297 · 2025: $1,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,066.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,037.38 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Na |
| Forte Bio-Pharma LLC | $1,047.62 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Scilex Pharmaceuticals INC. | $962.08 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $645.61 | 2019-2025 | Belbuca |
| Arbor Pharmaceuticals, INC. | $410.19 | 2019-2021 | |
| Nevro Corp. | $380.01 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $235.30 | 2019-2025 | Relistor |
| Abbvie INC. | $210.32 | 2021-2025 | |
| Medtronic, INC. | $196.77 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Amgen INC. | $190.34 | 2019-2022 | |
| Globus Medical, INC. | $159.28 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $154.82 | 2019-2020 | |
| Protega Pharmaceutials INC | $154.20 | 2023-2024 | Roxybond |
| Medtronic USA, INC. | $150.72 | 2019 | |
| Electronic Waveform Lab, INC. | $133.58 | 2019 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.